Home/ Stocks/ CELZ

Creative Medical Technology Holdings, Inc. Common Stock

CELZ XNAS

$1.42 +0.17 (+14.78%) ▲ 15-min delayed

Open

$1.47

High

$1.94

Low

$1.28

Volume

64.22M

Market Cap

$7.46M

About Creative Medical Technology Holdings, Inc. Common Stock

Creative Medical Technology Holdings Inc is a commercial-stage biotechnology company focused on the advancement of regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. Its pipeline consists of AlloStem (CELZ-201-DDT); ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, an intervention for the treatment of recent onset Type 1 Diabetes; AlloStemSpine for treatment of lower back pain; the Alova program to treat infertility as a result of premature ovarian failure; and other regenerative treatment programs and technologies like OvaStem, CaverStem, FemCelz, StemSpine, and others for the treatment of various indications related to sexual health, spine disc disease, kidney failure, liver failure, etc.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 4 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$0	$-1,403,717	N/A
FY 2025	$6.0K	$-5,995,008	N/A
Q3 2025	$0	$-1,235,934	N/A
Q2 2025	$0	$-1,233,303	N/A

Earnings & Analyst Ratings

Next Earnings: Thu, Nov 5, 2026

Calendar →

Related Market News

No specific coverage for CELZ yet. Check out our latest market news or earnings calendar.

Get CELZ Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Creative Medical Technology Holdings, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.